Clinical/Drug Discovery
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
Original research paper: Cell
doi:10.1016/j.cell.2011.06.001Enhanced epithelial-mesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing
M. Terao et al.
Original research paper: Journal of Biological Chemistry
doi:10.1074/jbc.M111.220376Recognition of the Major Cat Allergen Fel d 1 through the Cysteine-rich Domain of the Mannose Receptor Determines Its Allergenicity
M. Emara et al.
Original research paper: Journal of Biological Chemistry 286
doi:10.1074/jbc.M111.220657Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine
J. Kubler-kielb et al.
Original research paper: Proceedings of the National Academy of Sciences 108
doi:10.1073/pnas.1100782108Rational Design of an Aryl-C-Glycoside Catalyst from a Natural Product O-Glycosyltransferase
Johannes Härle et al.
Original research paper: Chemistry & Biology 18
doi:10.1016/j.chembiol.2011.02.0132-Glycoprotein I and Protection from Anti-SSA/Ro60-Associated Cardiac Manifestations of Neonatal Lupus
J. H. Reed et al.
Original research paper: The Journal of Immunology 187
doi:10.4049/jimmunol.1100122Acceptable changes in quality attributes of glycosylated biopharmaceuticals
Martin Schiestl et al.
Original research paper: Nature Biotechnology 29 310-312 (2011)
doi:10.1038/nbt.1839Design and synthesis of O-GlcNAcase inhibitors via ‘click chemistry’ and biological evaluations
Tiehai Li et al.
Original research paper: Carbohydrate Research 346
doi:10.1016/j.carres.2011.03.026Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma
P. Kamper et al.
Original research paper: Blood 117
doi:10.1182/blood-2010-12-327346Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis
Keriann M Backus et al.
Original research paper: Nature Chemical Biology 7
doi:10.1038/nchembio.539Cell-Penetrant, Nanomolar O-GlcNAcase Inhibitors Selective against Lysosomal Hexosaminidases
Helge C. Dorfmueller et al.
Original research paper: Chemistry & Biology 17
doi:10.1016/j.chembiol.2010.09.014Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
B. D. Wallace et al.
Original research paper: Science 330
doi:10.1126/science.1191175Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
N Matthew Ellinwood et al.
Original research paper: Molecular Therapy 19 251-259 (2010)
doi:10.1038/mt.2010.265Enzymatic synthesis of vancomycin derivatives using galactosyltransferase and sialyltransferase
Tae-Jin Oh et al.
Original research paper: The Journal of Antibiotics 64 103-109 (2010)
doi:10.1038/ja.2010.131O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1
Francesca Capotosti et al.
Original research paper: Cell 144
doi:10.1016/j.cell.2010.12.030Crosstalk between O-GlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway
S. Daou et al.
Original research paper: Proceedings of the National Academy of Sciences 108
doi:10.1073/pnas.1013822108Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia
Helene Hallböök et al.
Original research paper: PLoS ONE 6
doi:10.1371/journal.pone.0015718Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity
Jessica J. O’konek et al.
Original research paper: Journal of Clinical Investigation 121
doi:10.1172/JCI42314Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells
Tracey M Gloster et al.
Original research paper: Nature Chemical Biology 7 174-181 (2011)
doi:10.1038/nchembio.520
